1 Study Coverage 1.1 Powder Hemostatic Agent Product Introduction 1.2 Global Powder Hemostatic Agent Outlook 2017 VS 2022 VS 2028 1.2.1 Global Powder Hemostatic Agent Sales in US$ Million for the Year 2017-2028 1.2.2 Global Powder Hemostatic Agent Sales in Volume for the Year 2017-2028 1.3 United States Powder Hemostatic Agent Outlook 2017 VS 2022 VS 2028 1.3.1 United States Powder Hemostatic Agent Sales in US$ Million for the Year 2017-2028 1.3.2 United States Powder Hemostatic Agent Sales in Volume for the Year 2017-2028 1.4 Powder Hemostatic Agent Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.4.1 The Market Share of United States Powder Hemostatic Agent in Global, 2017 VS 2022 VS 2028 1.4.2 The Growth Rate of Powder Hemostatic Agent Market Size, United States VS Global, 2017 VS 2022 VS 2028 1.5 Powder Hemostatic Agent Market Dynamics 1.5.1 Powder Hemostatic Agent Industry Trends 1.5.2 Powder Hemostatic Agent Market Drivers 1.5.3 Powder Hemostatic Agent Market Challenges 1.5.4 Powder Hemostatic Agent Market Restraints 1.6 Study Objectives 1.7 Years Considered 2 Market by Type 2.1 Powder Hemostatic Agent Market Segment by Type 2.1.1 Absorbable Hemostatic Agent 2.1.2 Not Absorbable Hemostatic Agent 2.2 Global Powder Hemostatic Agent Market Size by Type 2.2.1 Global Powder Hemostatic Agent Sales in Value, by Type (2017, 2022 & 2028) 2.2.2 Global Powder Hemostatic Agent Sales in Volume, by Type (2017, 2022 & 2028) 2.2.3 Global Powder Hemostatic Agent Average Selling Price (ASP) by Type (2017, 2022 & 2028) 2.3 United States Powder Hemostatic Agent Market Size by Type 2.3.1 United States Powder Hemostatic Agent Sales in Value, by Type (2017, 2022 & 2028) 2.3.2 United States Powder Hemostatic Agent Sales in Volume, by Type (2017, 2022 & 2028) 2.3.3 United States Powder Hemostatic Agent Average Selling Price (ASP) by Type (2017, 2022 & 2028) 3 Market by Application 3.1 Powder Hemostatic Agent Market Segment by Application 3.1.1 Hospitals 3.1.2 Clinics 3.1.3 Home Care 3.2 Global Powder Hemostatic Agent Market Size by Application 3.2.1 Global Powder Hemostatic Agent Sales in Value, by Application (2017, 2022 & 2028) 3.2.2 Global Powder Hemostatic Agent Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 Global Powder Hemostatic Agent Average Selling Price (ASP) by Application (2017, 2022 & 2028) 3.3 United States Powder Hemostatic Agent Market Size by Application 3.3.1 United States Powder Hemostatic Agent Sales in Value, by Application (2017, 2022 & 2028) 3.3.2 United States Powder Hemostatic Agent Sales in Volume, by Application (2017, 2022 & 2028) 3.3.3 United States Powder Hemostatic Agent Average Selling Price (ASP) by Application (2017, 2022 & 2028) 4 Global Powder Hemostatic Agent Competitor Landscape by Company 4.1 Global Powder Hemostatic Agent Market Size by Company 4.1.1 Top Global Powder Hemostatic Agent Manufacturers Ranked by Revenue (2021) 4.1.2 Global Powder Hemostatic Agent Revenue by Manufacturer (2017-2022) 4.1.3 Global Powder Hemostatic Agent Sales by Manufacturer (2017-2022) 4.1.4 Global Powder Hemostatic Agent Price by Manufacturer (2017-2022) 4.2 Global Powder Hemostatic Agent Concentration Ratio (CR) 4.2.1 Powder Hemostatic Agent Market Concentration Ratio (CR) (2017-2022) 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Powder Hemostatic Agent in 2021 4.2.3 Global Powder Hemostatic Agent Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 4.3 Global Powder Hemostatic Agent Manufacturing Base Distribution, Product Type 4.3.1 Global Powder Hemostatic Agent Manufacturers, Headquarters and Distribution of Producing Region 4.3.2 Manufacturers Powder Hemostatic Agent Product Type 4.3.3 Date of International Manufacturers Enter into Powder Hemostatic Agent Market 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans 4.5 United States Powder Hemostatic Agent Market Size by Company 4.5.1 Top Powder Hemostatic Agent Players in United States, Ranked by Revenue (2021) 4.5.2 United States Powder Hemostatic Agent Revenue by Players (2020, 2021 & 2022) 4.5.3 United States Powder Hemostatic Agent Sales by Players (2020, 2021 & 2022) 5 Global Powder Hemostatic Agent Market Size by Region 5.1 Global Powder Hemostatic Agent Market Size by Region: 2017 VS 2022 VS 2028 5.2 Global Powder Hemostatic Agent Market Size in Volume by Region (2017-2028) 5.2.1 Global Powder Hemostatic Agent Sales in Volume by Region: 2017-2022 5.2.2 Global Powder Hemostatic Agent Sales in Volume Forecast by Region (2023-2028) 5.3 Global Powder Hemostatic Agent Market Size in Value by Region (2017-2028) 5.3.1 Global Powder Hemostatic Agent Sales in Value by Region: 2017-2022 5.3.2 Global Powder Hemostatic Agent Sales in Value by Region: 2023-2028 6 Segment in Region Level & Country Level 6.1 North America 6.1.1 North America Powder Hemostatic Agent Market Size YoY Growth 2017-2028 6.1.2 North America Powder Hemostatic Agent Market Facts & Figures by Country (2017, 2022 & 2028) 6.1.3 U.S. 6.1.4 Canada 6.2 Asia-Pacific 6.2.1 Asia-Pacific Powder Hemostatic Agent Market Size YoY Growth 2017-2028 6.2.2 Asia-Pacific Powder Hemostatic Agent Market Facts & Figures by Region (2017, 2022 & 2028) 6.2.3 China 6.2.4 Japan 6.2.5 South Korea 6.2.6 India 6.2.7 Australia 6.2.8 Taiwan 6.2.9 Indonesia 6.2.10 Thailand 6.2.11 Malaysia 6.2.12 Philippines 6.3 Europe 6.3.1 Europe Powder Hemostatic Agent Market Size YoY Growth 2017-2028 6.3.2 Europe Powder Hemostatic Agent Market Facts & Figures by Country (2017, 2022 & 2028) 6.3.3 Germany 6.3.4 France 6.3.5 U.K. 6.3.6 Italy 6.3.7 Russia 6.4 Latin America 6.4.1 Latin America Powder Hemostatic Agent Market Size YoY Growth 2017-2028 6.4.2 Latin America Powder Hemostatic Agent Market Facts & Figures by Country (2017, 2022 & 2028) 6.4.3 Mexico 6.4.4 Brazil 6.4.5 Argentina 6.5 Middle East and Africa 6.5.1 Middle East and Africa Powder Hemostatic Agent Market Size YoY Growth 2017-2028 6.5.2 Middle East and Africa Powder Hemostatic Agent Market Facts & Figures by Country (2017, 2022 & 2028) 6.5.3 Turkey 6.5.4 Saudi Arabia 6.5.5 U.A.E 7 Company Profiles 7.1 Johnson & Johnson（Ethicon） 7.1.1 Johnson & Johnson（Ethicon） Corporation Information 7.1.2 Johnson & Johnson（Ethicon） Description and Business Overview 7.1.3 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales, Revenue and Gross Margin (2017-2022) 7.1.4 Johnson & Johnson（Ethicon） Powder Hemostatic Agent Products Offered 7.1.5 Johnson & Johnson（Ethicon） Recent Development 7.2 Celox Medical 7.2.1 Celox Medical Corporation Information 7.2.2 Celox Medical Description and Business Overview 7.2.3 Celox Medical Powder Hemostatic Agent Sales, Revenue and Gross Margin (2017-2022) 7.2.4 Celox Medical Powder Hemostatic Agent Products Offered 7.2.5 Celox Medical Recent Development 7.3 Amed Therapeutics 7.3.1 Amed Therapeutics Corporation Information 7.3.2 Amed Therapeutics Description and Business Overview 7.3.3 Amed Therapeutics Powder Hemostatic Agent Sales, Revenue and Gross Margin (2017-2022) 7.3.4 Amed Therapeutics Powder Hemostatic Agent Products Offered 7.3.5 Amed Therapeutics Recent Development 7.4 Cryolife 7.4.1 Cryolife Corporation Information 7.4.2 Cryolife Description and Business Overview 7.4.3 Cryolife Powder Hemostatic Agent Sales, Revenue and Gross Margin (2017-2022) 7.4.4 Cryolife Powder Hemostatic Agent Products Offered 7.4.5 Cryolife Recent Development 7.5 BioCer Entwicklungs-GmbH 7.5.1 BioCer Entwicklungs-GmbH Corporation Information 7.5.2 BioCer Entwicklungs-GmbH Description and Business Overview 7.5.3 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales, Revenue and Gross Margin (2017-2022) 7.5.4 BioCer Entwicklungs-GmbH Powder Hemostatic Agent Products Offered 7.5.5 BioCer Entwicklungs-GmbH Recent Development 7.6 Yunnan Baiyao 7.6.1 Yunnan Baiyao Corporation Information 7.6.2 Yunnan Baiyao Description and Business Overview 7.6.3 Yunnan Baiyao Powder Hemostatic Agent Sales, Revenue and Gross Margin (2017-2022) 7.6.4 Yunnan Baiyao Powder Hemostatic Agent Products Offered 7.6.5 Yunnan Baiyao Recent Development 7.7 HHAO TECHNOLOGY 7.7.1 HHAO TECHNOLOGY Corporation Information 7.7.2 HHAO TECHNOLOGY Description and Business Overview 7.7.3 HHAO TECHNOLOGY Powder Hemostatic Agent Sales, Revenue and Gross Margin (2017-2022) 7.7.4 HHAO TECHNOLOGY Powder Hemostatic Agent Products Offered 7.7.5 HHAO TECHNOLOGY Recent Development 8 Industry Chain and Sales Channels Analysis 8.1 Powder Hemostatic Agent Industry Chain Analysis 8.2 Powder Hemostatic Agent Key Raw Materials 8.2.1 Key Raw Materials 8.2.2 Powder Hemostatic Agent Distributors 8.3 Powder Hemostatic Agent Production Mode & Process 8.4 Powder Hemostatic Agent Sales and Marketing 8.4.1 Powder Hemostatic Agent Sales Channels 8.4.2 Powder Hemostatic Agent Distributors 8.5 Powder Hemostatic Agent Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer

List of Tables Table 1. Powder Hemostatic Agent CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Powder Hemostatic Agent Market Trends Table 3. Powder Hemostatic Agent Market Drivers Table 4. Powder Hemostatic Agent Market Challenges Table 5. Powder Hemostatic Agent Market Restraints Table 6. Global Powder Hemostatic Agent Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Powder Hemostatic Agent Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Powder Hemostatic Agent Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Powder Hemostatic Agent Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Powder Hemostatic Agent Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Powder Hemostatic Agent Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Powder Hemostatic Agent Revenue Share by Manufacturer, 2017-2022 Table 13. Global Powder Hemostatic Agent Sales by Manufacturer, (K Units), 2017-2022 Table 14. Global Powder Hemostatic Agent Sales Share by Manufacturer, 2017-2022 Table 15. Global Powder Hemostatic Agent Price by Manufacturer (2017-2022) & (USD/Unit) Table 16. Global Powder Hemostatic Agent Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Powder Hemostatic Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Powder Hemostatic Agent as of 2021) Table 18. Top Players of Powder Hemostatic Agent in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Powder Hemostatic Agent Product Type Table 20. Date of International Manufacturers Enter into Powder Hemostatic Agent Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Powder Hemostatic Agent Players in United States Market, Ranking by Revenue (2021) Table 23. United States Powder Hemostatic Agent Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Powder Hemostatic Agent Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Powder Hemostatic Agent Sales by Players, (K Units), 2020, 2021 & 2022 Table 26. United States Powder Hemostatic Agent Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Powder Hemostatic Agent Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Powder Hemostatic Agent Sales in Volume by Region (2017-2022) & (K Units) Table 29. Global Powder Hemostatic Agent Sales in Volume Forecast by Region (2023-2028) & (K Units) Table 30. Global Powder Hemostatic Agent Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Powder Hemostatic Agent Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Powder Hemostatic Agent Sales in Volume by Country (2017-2028) & (K Units) Table 33. North America Powder Hemostatic Agent Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Powder Hemostatic Agent Sales in Volume by Region (2017-2028) & (K Units) Table 35. Asia Pacific Powder Hemostatic Agent Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Powder Hemostatic Agent Sales in Volume by Country (2017-2028) & (K Units) Table 37. Europe Powder Hemostatic Agent Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Powder Hemostatic Agent Sales in Volume by Country (2017-2028) & (K Units) Table 39. Latin Americaa Powder Hemostatic Agent Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Powder Hemostatic Agent Sales in Volume by Country (2017-2028) & (K Units) Table 41. Middle East and Africa Powder Hemostatic Agent Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Johnson & Johnson（Ethicon） Corporation Information Table 43. Johnson & Johnson（Ethicon） Description and Business Overview Table 44. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 45. Johnson & Johnson（Ethicon） Powder Hemostatic Agent Product Table 46. Johnson & Johnson（Ethicon） Recent Development Table 47. Celox Medical Corporation Information Table 48. Celox Medical Description and Business Overview Table 49. Celox Medical Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 50. Celox Medical Product Table 51. Celox Medical Recent Development Table 52. Amed Therapeutics Corporation Information Table 53. Amed Therapeutics Description and Business Overview Table 54. Amed Therapeutics Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 55. Amed Therapeutics Product Table 56. Amed Therapeutics Recent Development Table 57. Cryolife Corporation Information Table 58. Cryolife Description and Business Overview Table 59. Cryolife Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 60. Cryolife Product Table 61. Cryolife Recent Development Table 62. BioCer Entwicklungs-GmbH Corporation Information Table 63. BioCer Entwicklungs-GmbH Description and Business Overview Table 64. BioCer Entwicklungs-GmbH Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 65. BioCer Entwicklungs-GmbH Product Table 66. BioCer Entwicklungs-GmbH Recent Development Table 67. Yunnan Baiyao Corporation Information Table 68. Yunnan Baiyao Description and Business Overview Table 69. Yunnan Baiyao Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 70. Yunnan Baiyao Product Table 71. Yunnan Baiyao Recent Development Table 72. HHAO TECHNOLOGY Corporation Information Table 73. HHAO TECHNOLOGY Description and Business Overview Table 74. HHAO TECHNOLOGY Powder Hemostatic Agent Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 75. HHAO TECHNOLOGY Product Table 76. HHAO TECHNOLOGY Recent Development Table 77. Key Raw Materials Lists Table 78. Raw Materials Key Suppliers Lists Table 79. Powder Hemostatic Agent Customers List Table 80. Powder Hemostatic Agent Distributors List Table 81. Research Programs/Design for This Report Table 82. Key Data Information from Secondary Sources Table 83. Key Data Information from Primary Sources List of Figures Figure 1. Powder Hemostatic Agent Product Picture Figure 2. Global Powder Hemostatic Agent Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Powder Hemostatic Agent Market Size 2017-2028 (US$ Million) Figure 4. Global Powder Hemostatic Agent Sales 2017-2028 (K Units) Figure 5. United States Powder Hemostatic Agent Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Powder Hemostatic Agent Market Size 2017-2028 (US$ Million) Figure 7. United States Powder Hemostatic Agent Sales 2017-2028 (K Units) Figure 8. United States Powder Hemostatic Agent Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Powder Hemostatic Agent Market Share in Global, in Volume (K Units) 2017-2028 Figure 10. Powder Hemostatic Agent Report Years Considered Figure 11. Product Picture of Absorbable Hemostatic Agent Figure 12. Product Picture of Not Absorbable Hemostatic Agent Figure 13. Global Powder Hemostatic Agent Market Share by Type in 2022 & 2028 Figure 14. Global Powder Hemostatic Agent Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Powder Hemostatic Agent Sales Market Share in Value by Type (2017-2028) Figure 16. Global Powder Hemostatic Agent Sales by Type (2017-2028) & (K Units) Figure 17. Global Powder Hemostatic Agent Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Powder Hemostatic Agent Price by Type (2017-2028) & (USD/Unit) Figure 19. United States Powder Hemostatic Agent Market Share by Type in 2022 & 2028 Figure 20. United States Powder Hemostatic Agent Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Powder Hemostatic Agent Sales Market Share in Value by Type (2017-2028) Figure 22. United States Powder Hemostatic Agent Sales by Type (2017-2028) & (K Units) Figure 23. United States Powder Hemostatic Agent Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Powder Hemostatic Agent Price by Type (2017-2028) & (USD/Unit) Figure 25. Product Picture of Hospitals Figure 26. Product Picture of Clinics Figure 27. Product Picture of Home Care Figure 28. Global Powder Hemostatic Agent Market Share by Application in 2022 & 2028 Figure 29. Global Powder Hemostatic Agent Sales in Value by Application (2017-2028) & (US$ Million) Figure 30. Global Powder Hemostatic Agent Sales Market Share in Value by Application (2017-2028) Figure 31. Global Powder Hemostatic Agent Sales by Application (2017-2028) & (K Units) Figure 32. Global Powder Hemostatic Agent Sales Market Share in Volume by Application (2017-2028) Figure 33. Global Powder Hemostatic Agent Price by Application (2017-2028) & (USD/Unit) Figure 34. United States Powder Hemostatic Agent Market Share by Application in 2022 & 2028 Figure 35. United States Powder Hemostatic Agent Sales in Value by Application (2017-2028) & (US$ Million) Figure 36. United States Powder Hemostatic Agent Sales Market Share in Value by Application (2017-2028) Figure 37. United States Powder Hemostatic Agent Sales by Application (2017-2028) & (K Units) Figure 38. United States Powder Hemostatic Agent Sales Market Share in Volume by Application (2017-2028) Figure 39. United States Powder Hemostatic Agent Price by Application (2017-2028) & (USD/Unit) Figure 40. North America Powder Hemostatic Agent Sales in Volume Growth Rate 2017-2028 (K Units) Figure 41. North America Powder Hemostatic Agent Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 42. U.S. Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 43. Canada Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Europe Powder Hemostatic Agent Sales in Volume Growth Rate 2017-2028 (K Units) Figure 45. Europe Powder Hemostatic Agent Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 46. Germany Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 47. France Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. U.K. Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. Italy Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Russia Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Asia-Pacific Powder Hemostatic Agent Sales in Volume Growth Rate 2017-2028 (K Units) Figure 52. Asia-Pacific Powder Hemostatic Agent Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 53. China Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 54. Japan Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. South Korea Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. India Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. Australia Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Taiwan Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Indonesia Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Thailand Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Malaysia Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Philippines Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Latin America Powder Hemostatic Agent Sales in Volume Growth Rate 2017-2028 (K Units) Figure 64. Latin America Powder Hemostatic Agent Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 65. Mexico Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 66. Brazil Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Argentina Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Middle East & Africa Powder Hemostatic Agent Sales in Volume Growth Rate 2017-2028 (K Units) Figure 69. Middle East & Africa Powder Hemostatic Agent Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 70. Turkey Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 71. Saudi Arabia Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. U.A.E Powder Hemostatic Agent Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. Powder Hemostatic Agent Value Chain Figure 74. Powder Hemostatic Agent Production Process Figure 75. Channels of Distribution Figure 76. Distributors Profiles Figure 77. Bottom-up and Top-down Approaches for This Report Figure 78. Data Triangulation Figure 79. Key Executives Interviewed

Johnson & Johnson（Ethicon） Celox Medical Amed Therapeutics Cryolife BioCer Entwicklungs-GmbH Yunnan Baiyao HHAO TECHNOLOGY